InventisBio Co., Limited (SHA:688382)
China · Delayed Price · Currency is CNY 21.39
+1.42 (7.11%)
At close: Mar 6, 2026
InventisBio Market Cap
InventisBio has a market cap or net worth of 12.37 billion as of March 6, 2026. Its market cap has increased by 61.27% in one year.
Market Cap
12.37B
Enterprise Value
10.86B
Revenue
37.33M
Ranking
n/a
PE Ratio
n/a
Stock Price
21.39
Market Cap Chart
Since July 25, 2022, InventisBio's market cap has increased from 8.79B to 12.37B, an increase of 40.71%. That is a compound annual growth rate of 9.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 12.37B | -21.48% |
| Dec 31, 2025 | 15.75B | 105.38% |
| Dec 31, 2024 | 7.67B | -11.89% |
| Dec 29, 2023 | 8.71B | 14.01% |
| Dec 30, 2022 | 7.64B | -13.15% |
| Jul 25, 2022 | 8.79B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vcanbio Cell & Gene Engineering Corp., | 12.81B |
| Star Lake Bioscience Co., Inc.Zhaoqing Guangdong | 12.66B |
| Mabwell (Shanghai) Bioscience | 12.53B |
| Chengdu Olymvax Biopharmaceuticals | 11.88B |
| Staidson (Beijing) BioPharmaceuticals | 11.66B |
| Hualan Biological Vaccine | 11.25B |
| Beijing Hotgen Biotech | 10.78B |
| Chengzhi | 10.45B |